OPKO Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. on May 18, 2023. The report details a meeting of the Compensation Committee of the Board of Directors held on the same date to review and approve compensation matters for executive officers and non-executive employees.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation adjustments.
Material Changes and Compensation Details
The Compensation Committee approved the following grants for Named Executive Officers (NEOs):
- Stock Options: Granted with an exercise price of $1.58 per share. Options vest ratably over four years and expire on the tenth anniversary of the grant date.
- Bonus Payments: Approved cash bonuses for the listed officers.
| Name | Title | Stock Options Granted | Bonus Payment |
|---|---|---|---|
| Phillip Frost | Chief Executive Officer/Chairman | 800,000 | $480,000 |
| Jane H. Hsiao | Vice Chairman/Chief Technical Officer | 800,000 | $450,000 |
| Elias Zerhouni | Vice Chairman/President | 800,000 | $450,000 |
| Steven D. Rubin | Executive Vice President | 700,000 | $400,000 |
| Adam Logal | Senior Vice President/Chief Financial Officer | 700,000 | $375,000 |
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on business strategy, or specific risk factors beyond the standard disclosure of compensation arrangements.
Key Facts for Investor Verification
- Verify the total number of shares authorized for issuance under the company's equity incentive plans to ensure sufficient capacity for these grants.
- Confirm the current market price of OPKO common stock relative to the $1.58 exercise price to assess the intrinsic value of the options.
- Review the company's most recent 10-Q or 10-K for cash flow status to evaluate the impact of the $2.155 million in total approved bonuses on liquidity.
- Check for any subsequent filings regarding the vesting schedules or potential acceleration clauses for these equity awards.